Our findings highlight the significance of astrocytes in the removal of tau protein via the HDAC7-TFEB lysosomal pathway, indicating its potential as a therapeutic target for the treatment of AD and other tauopathies. The gene discussed is HDAC7; the disease is tauopathy.